Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.
about
Cross-regulation of TNF and IFN-alpha in autoimmune diseasesBlockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like diseaseHuman lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1.Normal serum levels of immune complexes in postpolio patientsNaja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr MiceSoluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10Pathologic patterns of interleukin 10 expression--a review.Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis.Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets.The immunopathology of experimental visceral leishmaniasis.Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responsesAnti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.Immune complexes isolated from patients with pulmonary tuberculosis modulate the activation and function of normal granulocytesSerum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.Cytokines and their receptors as biomarkers of systemic lupus erythematosus.Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.Regulatory T-cell-associated cytokines in systemic lupus erythematosus.Immunomodulators in SLE: Clinical evidence and immunologic actions.Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients.Selective regulation of autoreactive B cells by FcgammaRIIB.High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering.IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production.Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics.Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration.Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
P2860
Q24556513-88C754A5-5E58-43C4-990A-A42D1695FC60Q28590296-C8A6E289-46E4-4E22-BD82-9894E63FEA76Q33731760-98507802-09AE-4F1F-8114-2055D91BA085Q33781055-51533168-34BC-40E5-B720-3282FBF3092BQ33857872-75BD7E16-0535-4E1E-A789-ACF9609E5776Q33908254-CD99F94F-9ADF-439F-8EC3-D8B6FAC1D26DQ34259885-45FDE183-14AD-4C43-AA4F-62DB38A466EBQ34667904-21BE4437-704B-4C60-815C-86239B02C6ADQ34897560-BCA61503-E2EF-4CEB-A2B1-9A69A35B9A62Q35065604-AB1D54E5-BC31-4EAF-B471-D1656764B685Q35672923-ABAE8FC8-BCE7-4AD0-8E18-62BA510D197FQ35884243-85151508-858B-4592-A8B1-50EAEC3A9ABDQ36126960-F6AF0046-B6E2-445D-9BC1-42932DC2D5D6Q36245913-AFA1B2CD-AA96-445B-B0F9-75C3E19CB026Q36505215-150AE907-3048-44AB-9E07-01FE247B9099Q36907736-9EC97E77-C290-4EC0-A898-B32E42DDB471Q37118987-684698D4-681A-464B-8C8D-79142F34644EQ37751877-88951DA3-1D72-457A-B9F6-5FA9E30F8894Q37973328-67EC5343-0C71-4598-B155-9DB03FEB244FQ38883883-2EB4083A-8D9E-42FE-B20A-171DB9DC43D2Q40260152-33FA653C-46BA-4578-B5F0-D1E63C54F92DQ41970239-C9778CBA-9324-400C-AC3D-1C78BFC7944DQ41987472-CAD967E0-10A7-4B4B-891A-6B490DD235D0Q42956804-61B78241-6B86-4A9C-84AE-525BD0AD62DDQ44285833-4F18FC2E-4F89-4781-AFDE-AC0E91F7BB85Q46532671-496FD4B7-5467-493C-9B4A-0B2E41F884D7Q58694714-32EFB429-AFFA-4EA6-88E6-68C25F8BD5C0
P2860
Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@ast
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@en
type
label
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@ast
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@en
prefLabel
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@ast
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@en
P2093
P2860
P356
P1476
Immune complexes from SLE sera ...... g B cell hyperactivity in SLE.
@en
P2093
Mathsson L
Nilsson-Ekdahl K
Rönnelid J
P2860
P356
10.1136/ARD.62.1.37
P407
P50
P577
2003-01-01T00:00:00Z